DE69528291T2 - NON-BETA OXIDIZABLE FATTY ACID ANALOGS, THEIR USE AS A THERAPEUTICALLY ACTIVE MEDICINE AND THE PRODUCTION THEREOF - Google Patents

NON-BETA OXIDIZABLE FATTY ACID ANALOGS, THEIR USE AS A THERAPEUTICALLY ACTIVE MEDICINE AND THE PRODUCTION THEREOF

Info

Publication number
DE69528291T2
DE69528291T2 DE69528291T DE69528291T DE69528291T2 DE 69528291 T2 DE69528291 T2 DE 69528291T2 DE 69528291 T DE69528291 T DE 69528291T DE 69528291 T DE69528291 T DE 69528291T DE 69528291 T2 DE69528291 T2 DE 69528291T2
Authority
DE
Germany
Prior art keywords
sub
beta
production
fatty acid
therapeutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69528291T
Other languages
German (de)
Other versions
DE69528291D1 (en
Inventor
Rolf Berge
Jon Songstad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69528291D1 publication Critical patent/DE69528291D1/en
Application granted granted Critical
Publication of DE69528291T2 publication Critical patent/DE69528291T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Use is disclosed of non-β-oxidizable fatty acids analogues of the general formula (I)         Alkyl-X-CH<sub>2</sub>COORwherein alkyl represents a saturated or unsaturated hydrocarbon group of from 8-26 carbon atoms, X represents a sulphur atom and R is hydrogen or C<sub>1</sub>-C<sub>4</sub> alkyl, for the manufacture of a medicament to reduce the growth of cancer cells.
DE69528291T 1995-07-14 1995-10-25 NON-BETA OXIDIZABLE FATTY ACID ANALOGS, THEIR USE AS A THERAPEUTICALLY ACTIVE MEDICINE AND THE PRODUCTION THEREOF Expired - Fee Related DE69528291T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO952796A NO952796D0 (en) 1995-07-14 1995-07-14 Fatty acid analogues with non-oxidizable B-site, preparation and use in crepes
PCT/NO1995/000195 WO1997003663A1 (en) 1995-07-14 1995-10-25 NON-β-OXIDIZABLE FATTY ACID ANALOGUES, THEIR USES AS THERAPEUTIC ACTIVE MEDICAMENTS, AND PREPARATION THEREOF

Publications (2)

Publication Number Publication Date
DE69528291D1 DE69528291D1 (en) 2002-10-24
DE69528291T2 true DE69528291T2 (en) 2003-05-08

Family

ID=19898394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528291T Expired - Fee Related DE69528291T2 (en) 1995-07-14 1995-10-25 NON-BETA OXIDIZABLE FATTY ACID ANALOGS, THEIR USE AS A THERAPEUTICALLY ACTIVE MEDICINE AND THE PRODUCTION THEREOF

Country Status (13)

Country Link
US (1) US6046237A (en)
EP (3) EP1232750A1 (en)
JP (1) JP3553966B2 (en)
KR (1) KR100394986B1 (en)
AT (1) ATE224188T1 (en)
AU (2) AU4272696A (en)
CA (1) CA2226871A1 (en)
DE (1) DE69528291T2 (en)
DK (1) DK0840604T3 (en)
ES (1) ES2183889T3 (en)
NO (1) NO952796D0 (en)
PT (1) PT840604E (en)
WO (1) WO1997003663A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
AU784116B2 (en) * 1999-09-17 2006-02-09 Peplin Biolipids Pty Ltd Anti-cancer nitro- and thia-fatty acids
NO328803B1 (en) * 2000-03-03 2010-05-18 Thia Medica New fatty acid analogues
NO20003591L (en) * 2000-07-13 2002-01-14 Thia Medica As Fatty acid analogues for the treatment of cancer
NO20006008L (en) * 2000-11-28 2002-05-29 Thia Medica As Fatty acid analogues for the treatment of inflammatory and autoimmune diseases
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
FR2828487B1 (en) 2001-08-09 2005-05-27 Genfit S A NOVEL COMPOUNDS DERIVED FROM FATTY ACIDS, PREPARATION AND USES
CA2486303C (en) * 2002-05-22 2013-04-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
AU2003278602C1 (en) 2002-06-20 2010-08-12 Pronova Biopharma Norge As Sulfur-containing phospholipid derivatives
AU2003291097A1 (en) * 2002-11-20 2004-06-15 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
FR2850650B1 (en) * 2003-01-31 2005-03-25 Genfit S A THERAPEUTIC USE OF ACYLGLYCEROLS AND THEIR NITROGEN AND SULFUR ANALOGUES
FR2850869B1 (en) * 2003-02-12 2005-03-25 Genfit S A USES OF ACYLATED AMINOPROPANEDIOLS AND THEIR NITROGEN AND SULFUR ANALOGUES
EP1718602A4 (en) * 2004-01-30 2007-12-12 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
US7659242B2 (en) * 2004-07-19 2010-02-09 Thia Medica As Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities
WO2006052916A2 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Histone deacetylase inhibitors
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
AU2014228387B2 (en) 2013-03-11 2016-09-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
CN105498622B (en) * 2015-12-10 2017-10-17 江南大学 A kind of surfactant containing selenium and its preparation method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2208533A1 (en) * 1972-02-23 1973-09-27 Kolmar Laboratories Long chain alkyl thioethers - surfactants, bacteriostats fungistats and anticancer agents
GB8813012D0 (en) * 1988-06-02 1988-07-06 Norsk Hydro As Non-b-oxidizable fatty acid analogues to reduce concentration of cholesterol & triglycerides in blood of mammals

Also Published As

Publication number Publication date
PT840604E (en) 2003-01-31
AU734431B2 (en) 2001-06-14
ES2183889T3 (en) 2003-04-01
EP0840604A1 (en) 1998-05-13
EP0840604B1 (en) 2002-09-18
DE69528291D1 (en) 2002-10-24
JP3553966B2 (en) 2004-08-11
CA2226871A1 (en) 1997-02-06
US6046237A (en) 2000-04-04
KR19990028993A (en) 1999-04-15
JPH11514339A (en) 1999-12-07
ATE224188T1 (en) 2002-10-15
AU6124300A (en) 2000-11-30
WO1997003663A1 (en) 1997-02-06
EP1232750A1 (en) 2002-08-21
EP1232749A1 (en) 2002-08-21
KR100394986B1 (en) 2004-01-24
AU4272696A (en) 1997-02-18
NO952796D0 (en) 1995-07-14
DK0840604T3 (en) 2002-12-30

Similar Documents

Publication Publication Date Title
DE69528291D1 (en) NON-BETA OXIDIZABLE FATTY ACID ANALOGS, THEIR USE AS A THERAPEUTICALLY ACTIVE MEDICINE AND THE PRODUCTION THEREOF
EP0345038A3 (en) Non-beta-oxidizable fatty acid analogues with the effect to reduce the concentration of cholesterol and triglycerides in blood of mammals
ES2131207T3 (en) AMIDAS DERIVATIVES OF VALPROIC ACID AND 2-VALPROENOIC ACID AND ITS USE AS ANTICONVULSIVES.
AU564842B2 (en) Pyranyl (or cyclohexyl) methane sulfamates and their use as anticonvulsants
KR830006174A (en) Bronchial Anticonvulsant Compounds
ES484168A1 (en) 9-Hydroxyalkyl-purines, processes for preparing them and therapeutical composition containing the 9-hydroxyalkyl-purines as active ingredients.
FR2691968B1 (en) NEW PROCESS FOR THE PREPARATION OF A 11-CETO STEROUID DERIVATIVE.
ES2004141A6 (en) 1,4-Dihydropyridines, processes for their preparation and their use as antithrombotic drugs.
GR852867B (en)
FR2440353A1 (en) NOVEL ARYLETHANOLS, PROCESSES FOR OBTAINING THEM AND THEIR USE AS A MEDICINAL PRODUCT
AU586477B2 (en) Hexenoic acids
ATE37393T1 (en) MICROORGANISM STRAIN CHROMOBACTERIUM VIOLACEUM, PHARMACEUTICALLY ACTIVE COMPOUNDS PRODUCED THEREOF, A PROCESS FOR THEIR MANUFACTURE AND THEIR USE AS MEDICATIONS.
ATE144507T1 (en) DITHIAN SUBSTITUTED RETINOIDS, THEIR USE, METHOD FOR THE PRODUCTION THEREOF, COSMETIC AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR THERAPEUTIC USE
KR880012544A (en) Benzenesulfonamide Derivatives and Preparation Methods Thereof
SE9701912D0 (en) Pharmaceutical composition and use thereof
ATE27459T1 (en) 17-ALPHA-PREGN-4-ENE-3-OXO-21-CARBONATE, PROCESS FOR THEIR PRODUCTION AND USE IN PHARMACEUTICALS.
KR910000648A (en) Phenoxypyridinamine and its derivatives, preparation methods and uses as medicaments
ATE1422T1 (en) PROSTAGLANDINAL ANALOG IMIDAZOLE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM.
KR940005279A (en) Pharmaceutical Compositions Containing Amidine and Amidine
FR2485000B1 (en)
EP0653206A4 (en) Anti-hiv agent.
DE3683073D1 (en) 3-OXO-2-AZABICYCLOHEXANE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE OF THESE DERIVATIVES AS INTERMEDIATE COMPOUNDS FOR ANTIBACTERIAL ACTIVE SUBSTANCES.
HUT54371A (en) Process for producing macrolide compounds and pharmaceutical compositions containing them as active components
DE69327092T2 (en) OPTICALLY ACTIVE 1-PHENYLPYRROLIDONE DERIVATIVE AND THE PRODUCTION THEREOF
IT1250625B (en) DERIVATIVES OF HESERIDINE USEFUL FOR THE TREATMENT OF DISEASES ASSOCIATED WITH COLINERGIC DISORDERS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee